INOVIO announces pricing of $25M public offering

5 days ago 1

INOVIO Pharmaceuticals (NASDAQ:INO) on Thursday priced an underwritten public offering of 14.29 million shares of its common stock, along with accompanying Series A and Series B warrants to purchase up to an additional 28.57 million shares. Each share of common stock

Recommended For You